personal genomics:
Category: ashg2009
Personal genomics company 23andMe presented today at the American Society of Human Genetics meeting on novel genetic associations generated by the company using data from their customer base. The presentation showed that the company is capable of doing solid science, although it also raised worrying questions about the validity of survey results from customers who've already seen their genetic data.
Read on »
Posted by Daniel MacArthur at 5:30 AM • 10 Comments •
Category: personal genomics
Details are pretty sketchy, but a press release announced today suggests that personal genomics company 23andMe has performed a genome-wide association study comparing 100 current or former professional NFL players with a set of controls of unspecified sample size.The...
Read on »
Posted by Daniel MacArthur at 12:30 PM • 23 Comments •
Category: commercial genetic testing
An opinion piece in Nature by scientists including J. Craig Venter calls for changes to the approaches personal genomics companies use to select risk prediction markers and display information to customers.
Read on »
Posted by Daniel MacArthur at 9:20 PM • 17 Comments •
Category: direct-to-consumer genetic testing
Personal genomics company 23andMe is considering offering discounted genome scans to clinicians to help them to make sense of the complexities of modern common disease genetics.
Read on »
Posted by Daniel MacArthur at 10:00 AM • 5 Comments •
Category: commercial genetic testing
In part 2 of a three-part series of guest post, lawyers Daniel Vorhaus and Lawrence Moore analyse the legal repercussions of a personal genomics company going bankrupt - what will happen to your data?
Read on »
Posted by Daniel MacArthur at 9:00 AM • 2 Comments •
Category: direct-to-consumer genetic testing
In the first of three guest posts, lawyers Daniel Vorhaus and Lawrence Moore explore the intriguing question of what happens to customers' genetic data when a personal genomics company goes bankrupt.
Read on »
Posted by Daniel MacArthur at 9:00 AM • 8 Comments •
Category: direct-to-consumer genetic testing
The New York Times has an article pushing the possible dangers of customers peering into their own genome without supervision - but what supervision should customers look for, given that most doctors know less about modern genetics than the customers themselves?
Read on »
Posted by Daniel MacArthur at 2:30 PM • 30 Comments •
Category: next-generation sequencing
Sequencing company Illumina has delivered its first commercial personal whole genome sequence to entrepreneur Hermann Hauser.
Read on »
Posted by Daniel MacArthur at 5:30 AM • 6 Comments •
Category: personal utility
Dan Vorhaus has a great post in Genomics Law Report outlining recommendations made by a recent NIH-CDC workshop on the scientific foundations of personal genomics. The workshop included key stake-holders from academia, policy advisory groups and the personal genomics...
Read on »
Posted by Daniel MacArthur at 6:20 AM • 3 Comments •
Category: personal genomics
The Public Health Genomics Foundation's Caroline Wright reviews a recent paper exploring the changes personal genomics customers are likely to experience in their risk predictions as genetic research advances.
Read on »
Posted by Daniel MacArthur at 9:45 AM • 3 Comments •
